L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.


BACKGROUND Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) remains a major cause of mortality. Clinical criteria of AECOPD are subjective. Biomarkers for AECOPD may aid in the initiation of early treatment. Increased production of asymmetric and symmetric dimethylarginine (ADMA, SDMA) is related to hypoxia. In COPD, a rise in ADMA… (More)
DOI: 10.3109/15412555.2015.1045973

5 Figures and Tables


  • Presentations referencing similar topics